DE602006004713D1 - Trifluormethylbenzamidderivate und therapeutische verwendungen dafür - Google Patents
Trifluormethylbenzamidderivate und therapeutische verwendungen dafürInfo
- Publication number
- DE602006004713D1 DE602006004713D1 DE602006004713T DE602006004713T DE602006004713D1 DE 602006004713 D1 DE602006004713 D1 DE 602006004713D1 DE 602006004713 T DE602006004713 T DE 602006004713T DE 602006004713 T DE602006004713 T DE 602006004713T DE 602006004713 D1 DE602006004713 D1 DE 602006004713D1
- Authority
- DE
- Germany
- Prior art keywords
- trifluoromethylbenzamid
- derivatives
- therapeutic uses
- uses therefor
- therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0502479A FR2883000B1 (fr) | 2005-03-14 | 2005-03-14 | Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique |
PCT/EP2006/001374 WO2006097169A1 (en) | 2005-03-14 | 2006-02-16 | Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006004713D1 true DE602006004713D1 (de) | 2009-02-26 |
Family
ID=34981603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006004713T Active DE602006004713D1 (de) | 2005-03-14 | 2006-02-16 | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür |
Country Status (11)
Country | Link |
---|---|
US (1) | US7947675B2 (de) |
EP (1) | EP1858867B1 (de) |
JP (1) | JP5042987B2 (de) |
AR (1) | AR053340A1 (de) |
AT (1) | ATE420081T1 (de) |
AU (1) | AU2006224853B2 (de) |
CA (1) | CA2600904C (de) |
DE (1) | DE602006004713D1 (de) |
ES (1) | ES2317496T3 (de) |
FR (1) | FR2883000B1 (de) |
WO (1) | WO2006097169A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2009108280A (ru) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP970330B1 (en) * | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
US6207671B1 (en) | 1996-07-08 | 2001-03-27 | Bayer Aktiengesellschaft | Cycloalkano-pyridines |
JP2006502247A (ja) | 2002-07-12 | 2006-01-19 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 複素環で置換されたベンゾイル尿素、その製造方法および医薬としてのその使用 |
UA79300C2 (en) * | 2002-08-12 | 2007-06-11 | Janssen Pharmaceutica Nv | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
-
2005
- 2005-03-14 FR FR0502479A patent/FR2883000B1/fr not_active Expired - Fee Related
-
2006
- 2006-02-16 JP JP2008501173A patent/JP5042987B2/ja not_active Expired - Fee Related
- 2006-02-16 WO PCT/EP2006/001374 patent/WO2006097169A1/en not_active Application Discontinuation
- 2006-02-16 DE DE602006004713T patent/DE602006004713D1/de active Active
- 2006-02-16 US US11/908,712 patent/US7947675B2/en not_active Expired - Fee Related
- 2006-02-16 ES ES06706976T patent/ES2317496T3/es active Active
- 2006-02-16 AU AU2006224853A patent/AU2006224853B2/en not_active Ceased
- 2006-02-16 EP EP06706976A patent/EP1858867B1/de not_active Not-in-force
- 2006-02-16 AT AT06706976T patent/ATE420081T1/de not_active IP Right Cessation
- 2006-02-16 CA CA2600904A patent/CA2600904C/en not_active Expired - Fee Related
- 2006-03-14 AR ARP060100959A patent/AR053340A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ATE420081T1 (de) | 2009-01-15 |
US7947675B2 (en) | 2011-05-24 |
AU2006224853B2 (en) | 2011-08-18 |
FR2883000B1 (fr) | 2007-06-01 |
CA2600904A1 (en) | 2006-09-21 |
ES2317496T3 (es) | 2009-04-16 |
CA2600904C (en) | 2013-12-10 |
AR053340A1 (es) | 2007-05-02 |
EP1858867B1 (de) | 2009-01-07 |
AU2006224853A1 (en) | 2006-09-21 |
US20080119459A1 (en) | 2008-05-22 |
WO2006097169A1 (en) | 2006-09-21 |
JP5042987B2 (ja) | 2012-10-03 |
JP2008537933A (ja) | 2008-10-02 |
FR2883000A1 (fr) | 2006-09-15 |
EP1858867A1 (de) | 2007-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006004713D1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
ATE525088T1 (de) | Kombinationstherapie | |
ATE543825T1 (de) | Spiro-oxindolverbindungen und ihre verwendungen als therapeutische mittel | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
DK3424932T3 (da) | Bronophthalider til terapeutisk anvendelse | |
DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
DK1725553T3 (da) | Tetrahydropyridoindolderivater | |
ATE540935T1 (de) | Chinazolinderivate | |
DE602005009811D1 (de) | Tetrahydrocarbazole und derivate | |
DK1928457T3 (da) | Quinoliner og deres terapeutiske anvendelse | |
DE602006020061D1 (de) | Mucin-glycoprotein und anwendung davon | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
ATE500227T1 (de) | Amidderivate | |
DK1863899T3 (da) | Hudbehandlingspræparater | |
DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
DE602008001981D1 (de) | Stellung und therapeutische verwendung | |
DE112006001343A5 (de) | Patientenauflage | |
DE602005020457D1 (de) | Master-slave-flip-flop, trigger-flip-flop und zähler | |
DE602006000612D1 (de) | Beidseitig tragbare Orthese | |
DK1740574T3 (da) | 4-amino-5-cyanopyrimidinderivater | |
DE112006002272T8 (de) | Katheter und Katheter-Kit | |
DK1940840T3 (da) | 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |